BIOTALYS NV (BTLS.BR) Stock Analyst Earnings Estimates
EBR:BTLS - Euronext Brussels - BE0974386188 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 125.00% | N/A 24.69% | |||||||
| EBITDA YoY % growth | -8.65M | -12.24M -41.50% | -16.61M -35.70% | -20.956M -26.16% | -19.105M 8.83% | -11.664M 38.95% | N/A -26.80% | N/A 13.79% | N/A -179.35% | |
| EBIT YoY % growth | -9.24M | -13.28M -43.72% | -18.08M -36.14% | -22.531M -24.62% | -20.891M 7.28% | -13.492M 35.42% | N/A -13.40% | N/A 53.33% | N/A -42.86% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A 2.44% | N/A 5.00% | N/A | N/A -111.84% | N/A -1.24% | N/A -99.53% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 20% | 20% |